beta-lactams has been researched along with Peripheral Nerve Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassetti, M; Bouglé, A; Jung, B; Lavigne, JP; Legrand, M; Leone, M; Neely, M; Paiva, JA; Payen, D; Rello, J; Roberts, JA; Roger, C; Sjövall, F | 1 |
| Bonache, MÁ; Cuevas, C; de la Torre Martínez, R; Fernández-Ballester, G; Fernández-Carvajal, A; Ferrer-Montiel, A; Francesch, A; González-Muñiz, R; González-Rodríguez, S; Martín-Escura, C; Medina, A; Roa, AM | 1 |
| Ayaz, T; Kara, E; Sahin, OZ; Sahutoglu, T; Tufekci, A; Yildirim, S | 1 |
| Hori, S | 1 |
1 review(s) available for beta-lactams and Peripheral Nerve Diseases
| Article | Year |
|---|---|
[Adverse effects and safety of antimicrobial agents-neurotoxicities].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Diseases; Drug Interactions; Humans; Isoniazid; Neuromuscular Junction Diseases; Peripheral Nervous System Diseases; Quinolones; Tetracyclines | 2007 |
3 other study(ies) available for beta-lactams and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International Symposium.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Critical Care; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Drug Utilization; Drugs, Investigational; Europe; Extracorporeal Membrane Oxygenation; Forecasting; Humans; Intensive Care Units; Kidney Diseases; Microbial Sensitivity Tests; Microbiota; Nebulizers and Vaporizers; Peripheral Nervous System Diseases; Population Surveillance | 2019 |
Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity.
Topics: Analgesics; Animals; Antineoplastic Agents; beta-Lactams; Cell Line, Tumor; Cold Temperature; Computer Simulation; Cytophotometry; Drug Evaluation, Preclinical; Hyperalgesia; Male; Mice; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Oxaliplatin; Patch-Clamp Techniques; Peripheral Nervous System Diseases; Piperazines; Structure-Activity Relationship; TRPM Cation Channels | 2020 |
Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Electroencephalography; Electromyography; Enterococcus faecalis; Ertapenem; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Renal Insufficiency, Chronic; Risk Factors; Urinary Tract Infections | 2015 |